High-potency human immunodeficiency virus vaccination leads to delayed and reduced CD8+ T-cell expansion but improved virus control

被引:27
作者
Davenport, MP
Zhang, L
Bagchi, A
Fridman, A
Fu, TM
Schleif, W
Shiver, JW
Ribeiro, RM
Perelson, AS
机构
[1] Los Alamos Natl Lab, Los Alamos, NM 87545 USA
[2] Univ New S Wales, Prince Wales Hosp, Dept Haematol, Sydney, NSW 2052, Australia
[3] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia
[4] Merck Res Labs, W Point, PA 19486 USA
关键词
D O I
10.1128/JVI.79.15.10059-10062.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
CD8(+) T lymphocytes are thought to play an important role in the control of acute and chronic human immunodeficiency virus infections. However, there is a significant delay between infection and the first observed increase in virus-specific CD8(+) T-cell numbers. Prior to this time, viral kinetics are not significantly different between controls and vaccinees. Surprisingly, higher initial virus-specific CD8(+) T-cell numbers lead to a longer delay prior to initial CD8(+) T-cell expansion, and slower CD8(+) T-cell increases. Nevertheless, higher initial CD8(+) T-cell numbers were associated with reduced peak and chronic viral loads and reduced CD4(+) T-cell depletion.
引用
收藏
页码:10059 / 10062
页数:4
相关论文
共 12 条
  • [1] Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques
    Abdel-Motal, UM
    Gillis, J
    Manson, K
    Wyand, M
    Montefiori, D
    Stefano-Cole, K
    Montelaro, RC
    Altman, JD
    Johnson, RP
    [J]. VIROLOGY, 2005, 333 (02) : 226 - 238
  • [2] Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
    Amara, RR
    Villinger, F
    Altman, JD
    Lydy, SL
    O'Neil, SP
    Staprans, SI
    Montefiori, DC
    Xu, Y
    Herndon, JG
    Wyatt, LS
    Candido, MA
    Kozyr, NL
    Earl, PL
    Smith, JM
    Ma, HL
    Grimm, BD
    Hulsey, ML
    Miller, J
    McClure, HM
    McNicholl, JM
    Moss, B
    Robinson, HL
    [J]. SCIENCE, 2001, 292 (5514) : 69 - 74
  • [3] Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
    Barouch, DH
    Santra, S
    Schmitz, JE
    Kuroda, MJ
    Fu, TM
    Wagner, W
    Bilska, M
    Craiu, A
    Zheng, XX
    Krivulka, GR
    Beaudry, K
    Lifton, MA
    Nickerson, CE
    Trigona, WL
    Punt, K
    Freed, DC
    Guan, LM
    Dubey, S
    Casimiro, D
    Simon, A
    Davies, ME
    Chastain, M
    Strom, TB
    Gelman, RS
    Montefiori, DC
    Lewis, MG
    Emini, EA
    Shiver, JW
    Letvin, NL
    [J]. SCIENCE, 2000, 290 (5491) : 486 - 492
  • [4] Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
    Barouch, DH
    Kunstman, J
    Kuroda, MJ
    Schmitz, JE
    Santra, S
    Peyerl, FW
    Krivulka, GR
    Beaudry, K
    Lifton, MA
    Gorgone, DA
    Montefiori, DC
    Lewis, MG
    Wolinsky, SM
    Letvin, NL
    [J]. NATURE, 2002, 415 (6869) : 335 - 339
  • [5] Compromised influenza virus-specific CD8+-T-Cell memory in CD4+-T-cell-deficient mice
    Belz, GT
    Wodarz, D
    Diaz, G
    Nowak, MA
    Doherty, PC
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (23) : 12388 - 12393
  • [6] Predicting the impact of a nonsterilizing vaccine against human immunodeficiency virus
    Davenport, MP
    Ribeiro, RM
    Chao, DL
    Perelson, AS
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (20) : 11340 - 11351
  • [7] Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection
    Davenport, MP
    Ribeiro, RM
    Perelson, AS
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (18) : 10096 - 10103
  • [8] Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
    Goulder, PJR
    Phillips, RE
    Colbert, RA
    McAdam, S
    Ogg, G
    Nowak, MA
    Giangrande, P
    Luzzi, G
    Morgan, B
    Edwards, A
    McMichael, AJ
    RowlandJones, S
    [J]. NATURE MEDICINE, 1997, 3 (02) : 212 - 217
  • [9] Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
    Shiver, JW
    Fu, TM
    Chen, L
    Casimiro, DR
    Davies, ME
    Evans, RK
    Zhang, ZQ
    Simon, AJ
    Trigona, WL
    Dubey, SA
    Huang, LY
    Harris, VA
    Long, RS
    Liang, XP
    Handt, L
    Schleif, WA
    Zhu, L
    Freed, DC
    Persaud, NV
    Guan, L
    Punt, KS
    Tang, A
    Chen, MC
    Wilson, KA
    Collins, KB
    Heidecker, GJ
    Fernandez, VR
    Perry, HC
    Joyce, JG
    Grimm, KM
    Cook, JC
    Keller, PM
    Kresock, DS
    Mach, H
    Troutman, RD
    Isopi, LA
    Williams, DM
    Xu, Z
    Bohannon, KE
    Volkin, DB
    Montefiori, DC
    Miura, A
    Krivulka, GR
    Lifton, MA
    Kuroda, MJ
    Schmitz, JE
    Letvin, NL
    Caulfield, MJ
    Bett, AJ
    Youil, R
    [J]. NATURE, 2002, 415 (6869) : 331 - 335
  • [10] Could disease-modifying HIV vaccines cause population-level perversity?
    Smith, RJ
    Blower, SM
    [J]. LANCET INFECTIOUS DISEASES, 2004, 4 (10) : 636 - 639